click to access course materials from past events

click to upload a file to Camenae Group

Course Detail

GI Cancer Conference 2013: Liver Cancer – What Now?

OVERVIEW

The 2013 Gastrointestinal Cancer Conference is focused on liver tumors, both metastatic and primary. The forum will provide for the assessment and increase in competency related to the care of patients with benign and malignant liver tumors, including screening and diagnosis as well as the latest surgical and therapeutic management options for these tumors.

TARGET AUDIENCE

This conference is specifically designed for physicians, physician assistants and nurse practitioners interested in the prevention, screening, evaluation, and management of gastrointestinal cancers, including gastroenterologists, family practitioners, internists, surgeons, medical, surgical and radiation oncologists, radiologists and pathologists.

OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Discuss the screening, diagnosis, genetics, epidemiology, staging and current surgical management of colon cancer (CRC).
  • Describe the surveillance of patients with CRC, the incidence of liver metastases and treatment for unresectable and resectable metastases.
  • Review the diagnosis and treatment of benign liver tumors and cysts of the liver.
  • Summarize the treatment of cholangiocarcinoma and gallbladder cancer.
  • Review the incidence, prevalence and prognosis of liver tumors.
  • Summarize the latest radiological methods for evaluating real or potential liver masses.
  • Examine the clinical course of malignant liver tumors, both metastatic and primary.
  • Provide overview of the surgical treatment of liver metastases from breast cancer, melanoma, sarcoma and neuroendocrine carcinoma.
  • Interpret the clinical course of neuroendocrine tumors.
  • Identify the most effective treatment options for neuroendocrine metastases to the liver.
  • Describe treatment plans for liver tumors, including surgical resection, forms of ablation and other emerging techniques.
  • Discuss use of intro-arterial therapies for hepatocellular carcinoma (HCC).
  • Describe the management of HCC and requirements for and role of liver transplantation in HCC patients.

 

PROGRAM AGENDA

7:30 AM   Registration Continental Breakfast

8:00         Introduction
                 Alan Miller, MD, PhD
                 Chief of Oncology • Baylor Health Care System
                 Medical Director • Baylor Charles A. Sammons Cancer Center

8:05        Course Overview
                John Preskitt, MD

8:15        Current Treatment of Colo-Rectal Cancer (CRC)
                James Fleshman, MD

8:45        Hepatocellular Carcinoma (Part I)
                Doug Orr, MD

9:15        Overview of the Liver Mass
                Scott Celinski, MD

9:45        Radiological Caveats in Liver Tumors
                Gregory dePrisco, MD

10:15      BREAK

10:30      Hepatocellular Carcinoma (Part II)
                Mark Walberg, MD

11:00      Liver Metastases from Neuroendocrine Carcinoma and Other Causes
                Keith Cavaness, DO

11:30      CASE PRESENTATIONS AND DISCUSSION
                 Panel: Celinski, Papavasiliou, Orr, Kim, dePrisco
                 Moderator: Robert Goldstein, MD

12:15PM Lunch and Tours of the Cancer Center

1:30        Surgical Resection and Ablative Techniques for Liver Tumors
                Robert Goldstein, MD

2:00        Intra-arterial Therapies for Liver Cancer
                J.D. Meler, MD

2:30        Transplantation for Liver Tumors
                Giuliano Testa, MD

3:00        Closing Remarks, Evaluations, Adjourn

 

PROGRAM CHAIR

John Preskitt, MD
Surgical Oncologist
Director, Division of Surgical Oncology
Baylor Charles A. Sammons Cancer Center

PROGRAM FACULTY

Keith Cavaness, DO
Surgical Oncologist
Baylor Charles A. Sammons Cancer Center

Scott Celinski, MD
Surgical Oncologist
Baylor Charles A. Sammons Cancer Center

Gregory dePrisco, MD
Radiologist
American Radiology Associates

James Fleshman, MD
Chief of Surgery
Baylor University Medical Center

Robert Goldstein, MD
Hepatobiliary Surgeon
Director, Liver & Pancreas Disease Center
Baylor Charles A. Sammons Cancer Center

Peter Kim, MD
Hepatobiliary Surgeon
Baylor Charles A. Sammons Cancer Center

J.D. Meler, MD
Interventional Radiologist
Baylor Charles A. Sammons Cancer Center

Doug Orr, MD
Medical Oncologist
Baylor Charles A. Sammons Cancer Center

Pavlos Papavasiliou, MD
Surgical Oncologist
Baylor Charles A Sammons Cancer Center

Giuliano Testa, MD
Hepatobiliary Surgeon
Baylor Charles A. Sammons Cancer Center

Mark Walberg, MD
Medical Oncologist
Baylor Charles A. Sammons Cancer Center

REGISTRATION INFORMATION

Register online by clicking on the button above or CLICK HERE

TUITION FEES

Physicians - $99

NP - $49

PA - $49

RN/Allied Health - $49

Space is limited and early registration is advised.  Availability of on-site registration is not guaranteed.  Tuition includes continental breakfast, lunch, and refreshment breaks. Registrations are acknowledged by email only – please provide a valid email address so that you may receive a confirmation.  A $25 service charge will be added to returned checks and/or credit/debit card denials.  Preregistration Due Date: To qualify for the early registration rate, your registration information and payment must be received by Feb. 6, 2013.

ACCREDITATION

PHYSICIAN

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, and the Camenae Group, Inc. The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, is accredited by the ACCME to provide continuing medical education for physicians.

The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits(TM) Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANT

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(TM).

NURSE PRACTITIONER

AANP accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits(TM).

NURSING

The Camenae Group, Inc. is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity meets Type I criteria for mandatory continuing education requirements toward relicensure as established by the Board of Nurse Examiners for the State of Texas.

This activity provides 5.5 contact hours.

LODGING

A limited number of reduced rate rooms are available for participants wishing to stay overnight in the Dallas area at the Adolphus Hotel,1321 Commerce Street, Dallas, TX 75202.  To reserve a room, please call 800.221.9083, and request the Baylor GI Cancer Conference rate.